Metformin Effect on Brain Function in Insulin Resistant Elderly People
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Alzheimer's disease (AD) and other forms of dementia are rapidly increasing with the aging of
the population, and show a clear preponderance among people with insulin resistance.
Metformin, an insulin sensitizer, is being examined in clinical trials as an anti-aging drug.
However, very little objective data is available regarding metformin's effect on the brain, a
major organ affected by aging.